Glucagon‐Like Peptide‐2 Receptor: A Master Integrator of Gut‐Brain‐Liver Communication in Metabolic and Cognitive Health

Glucagon-like peptide-2 (GLP-2) has historically been defined by its primary role as an intestinal hormone essential for mucosal growth and epithelial barrier integrity. However, a surge of recent research has sparked a paradigm shift, recasting the GLP-2 receptor (GLP-2R) as a master orchestrator of communication between the gut, brain, and liver. This review synthesizes these advances, highlighting the receptor's strategic expression across this tripartite axis and its functional significance in bidirectional signaling pathways. We also detail its distinct quantitative distribution compared to the GLP-1 receptor (GLP-1R). We examine how GLP-2R serves as a molecular hub in these bidirectional signaling networks critical for both metabolic and cognitive health. Through convergent neural and endocrine pathways, GLP-2R modulates appetite, gastrointestinal motility, metabolic homeostasis, and neuroinflammatory processes that underpin cognitive function. These pathways include vagal afferent circuits, sympathetic innervation, and restricted central access via circumventricular organs. Notably, we also address species-specific differences in GLP-2R function and their critical translational significance for human therapeutics. This is particularly relevant regarding appetite regulation and pancreatic expression. We review the latest pharmacological innovations, including long-acting analogs, synergistic dual agonists, and novel delivery systems. These dual agonists specifically leverage the structural and signaling non-overlap between GLP-1R and GLP-2R to unlock the receptor's full therapeutic potential. Finally, we discuss ongoing challenges and highlight specific unanswered mechanistic questions. This positions GLP-2R as both a promising therapeutic target and a fundamental research tool for dissecting the integrated crosstalk between the gut, brain, and liver that governs whole-body physiology and behavior.

Authors

Institutions

Publication Details

Journal
Comprehensive physiology
Published
2026-04-01
DOI
https://doi.org/10.1002/cph4.70144
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Glucagon‐Like Peptide‐2 Receptor: A Master Integrator of Gut‐Brain‐Liver Communication in Metabolic and Cognitive Health

Guo Han, Mingdao Mu, Shengru Hu, Yunuo Jiang et al.
Comprehensive physiology
Diabetes Treatment and Management
article

Glucagon‐Like Peptide‐2 Receptor: A Master Integrator of Gut‐Brain‐Liver Communication in Metabolic and Cognitive Health

Guo Han, Mingdao Mu, Shengru Hu, Yunuo Jiang, Zixu Zhang
article en

Abstract

Glucagon-like peptide-2 (GLP-2) has historically been defined by its primary role as an intestinal hormone essential for mucosal growth and epithelial barrier integrity. However, a surge of recent research has sparked a paradigm shift, recasting the GLP-2 receptor (GLP-2R) as a master orchestrator of communication between the gut, brain, and liver. This review synthesizes these advances, highlighting the receptor's strategic expression across this tripartite axis and its functional significance in bidirectional signaling pathways. We also detail its distinct quantitative distribution compared to the GLP-1 receptor (GLP-1R). We examine how GLP-2R serves as a molecular hub in these bidirectional signaling networks critical for both metabolic and cognitive health. Through convergent neural and endocrine pathways, GLP-2R modulates appetite, gastrointestinal motility, metabolic homeostasis, and neuroinflammatory processes that underpin cognitive function. These pathways include vagal afferent circuits, sympathetic innervation, and restricted central access via circumventricular organs. Notably, we also address species-specific differences in GLP-2R function and their critical translational significance for human therapeutics. This is particularly relevant regarding appetite regulation and pancreatic expression. We review the latest pharmacological innovations, including long-acting analogs, synergistic dual agonists, and novel delivery systems. These dual agonists specifically leverage the structural and signaling non-overlap between GLP-1R and GLP-2R to unlock the receptor's full therapeutic potential. Finally, we discuss ongoing challenges and highlight specific unanswered mechanistic questions. This positions GLP-2R as both a promising therapeutic target and a fundamental research tool for dissecting the integrated crosstalk between the gut, brain, and liver that governs whole-body physiology and behavior.

Comprehensive physiologyVol. 16(2)
Southeast University (CN)
National Natural Science Foundation of China
Openalex Percentile: Top 7%
Diabetes Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Glucagon‐Like Peptide‐2 Receptor: A Master Integrator of Gut‐Brain‐Liver Communication in Metabolic and Cognitive Health — Guo Han, Mingdao Mu, et al. · Comprehensive physiology (2026) | TGRS Research Map | TGRS